Oral levosimendan, a novel myofilament calcium sensitizer, is an effective substitute for intravenous inotropic therapy in class IV inotrope-dependent heart failure patients

✍ Scribed by Jeffrey D. Hosenpud; James B. Young; Stuart D. Katz; Stephen S. Gottlieb; Lasse Lehtonen; Milton Packer

• Book ID: 119590153
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 141 KB
• Volume: 5
• Category: Article
• ISSN: 1532-8414
• DOI: 10.1016/s1071-9164(99)91505-1